Ultragenyx Pharmaceu (NQ: RARE )

103.48 USD -3.07 (-2.88%)

Official Closing Price Updated: 5:24 PM EDT, Apr 9, 2021 Add to My Watchlist

Price and Volume

Volume	325,400
Open	105.91
Bid (Size)	103.47 (1)
Ask (Size)	103.48 (4)
Prev. Close	106.55
Today's Range	101.15 - 105.91
52wk Range	51.21 - 179.65
Shares Outstanding	49,772,297
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX053, an mRNA for the Treatment of Glycogen Storage Disease Type III

March 08, 2021

Ultragenyx to Present at Barclays Global Healthcare Conference

March 03, 2021

Performance

YTD	-24.17%	-24.17%
1 Month	-13.74%	-13.74%
3 Month	-31.28%	-31.28%
6 Month	+9.56%	+9.56%
1 Year	+97.10%	+97.10%

More News

n-Lorem Foundation Partners with Ultragenyx to Bolster Development of Personalized Medicines for Patients with Ultra-Rare Diseases

April 05, 2021

Ultragenyx to Present at Upcoming Investor Conferences

February 17, 2021

Ultragenyx Announces Approval of Dojolvi™ (UX007/triheptanoin) in Canada for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Adults and Children

February 17, 2021

Ultragenyx Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Update

February 11, 2021

Implied PDP Analyst Target Price: $96

April 05, 2021

Ultragenyx Pharmaceutical Larger Than S&P 500 Component Alaska Air Group

March 09, 2021

First Week of March 19th Options Trading For Ultragenyx Pharmaceutical (RARE)

March 04, 2021

Ultragenyx Pharma Shows Market Leadership With Jump To 82 RS Rating

March 16, 2021

Ultragenyx's Dojolvi Ok'd In Canada For Genetic Metabolic Disorder

February 17, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.